FastFacts: Adenovirus Vector Manufacturing Platform Using CIMmultus QA Assures the Supply of Safe Vaccines

Watch the video or read the poster to learn:

  • Why downstream processing remains one of the main bottlenecks in adenoviral vector manufacturing
  • How an adenoviral vector purification platform using CIMmultus™ QA as the key purification step, secures a fast and robust process with better purity
  • CIMmultus QA offers high capacity and high yields of adenovirus, results in cost reduction and overcomes raw material supply bottlenecks

Hana Jug, Project Manager in process development for viral vectors and vaccines, Sartorius BIA Separations

    Your Cart
    Your cart is emptyReturn to Shop
      This site is registered on as a development site. Switch to a production site key to remove this banner.